CareFusion Corporation Falls After Preliminary 2Q Results


CareFusion Corporation (NYSE:CFN) plummeted 8.52% to $23.35 in the early hour after the company announced preliminary second quarter results in advance of a presentation by Chairman and CEO Kieran T. Gallahue at the annual J.P. Morgan Healthcare Conference.

The company expects second fiscal quarter revenue to be $910 million to $915 million and operating income to be $141 million to $146 million. Excluding nonrecurring items, adjusted operating income is expected to be $148 million to $153 million.

CareFusion expects income from continuing operations per diluted share (EPS) for the quarter to be $0.39 to $0.43, or $0.41 to $0.45 on an adjusted basis.

CareFusion continues to expect full-year consolidated revenue for fiscal 2012 to grow 3%to 5% on a constant currency basis compared to fiscal 2011 revenue of $3.53 billion. The company lowered the bottom end of its full-year adjusted EPS guidance range by $0.05, to a new range of $1.75 to $1.90.

The company’s medical systems segment continues to look good, with strong bookings in the quarter and good visibility through the second half of the year.

CareFusion is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care.

Disclaimer:

The assembled information distributed by headlineotc.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Headlineotc.com does expect that investors will buy and sell securities based on information assembled and presented herein. Headlineotc.com will not be responsible in any way for or accept any liability for any losses arising from an investor’s reliance on or use of information obtained from our website or emails. PLEASE always do your own due diligence, and consult your financial adviser.

Our Research Report on CFN is now available. Don´t Trade CFN until you Read our FREE FULL REPORT. Click Here